Pinnacle Financial Partners (Georgia)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Buy
697,936
+107,409
+18% +$2.81M 0.11% 145
2026
Q1
$16.6M Buy
590,527
+20,296
+4% +$540K 0.13% 139
2025
Q4
$14.2M Buy
+570,231
New +$14.4M 0.11% 151

Other funds holding PFE

Pinnacle Financial Partners (Georgia)'s PFE Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $2.81M and bringing the position to 697,936 shares worth $16.8M. The position accounts for 0.11% of the portfolio, ranked #145.

Pinnacle Financial Partners (Georgia) first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 697,936 shares of Pfizer worth $16.8M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 107,409 Pfizer shares in Q2 2026, an estimated $2.81M.
  • Pfizer made up 0.11% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #145 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.